National Journal to Launch National Journal’s Early Bird

See more stories about...
Nov. 1, 2013, 10:56 a.m.

Na­tion­al Journ­al to Launch Na­tion­al Journ­al‘s Early Bird

WASH­ING­TON, Nov. 1, 2013 — The Pentagon an­nounced today that it will no longer pro­duce the Early Bird, an early morn­ing news­let­ter with a de­voted fol­low­ing among the de­fense com­munity. On Monday, Na­tion­al Journ­al will fill the void with Na­tion­al Journ­al‘s Early Bird, a new early morn­ing news­let­ter that will of­fer the same up-to-the-second cov­er­age of de­fense policy that made the Pentagon’s product a must-read.

Na­tion­al Journ­al‘s Early Bird will be de­livered at no cost to those who sign up at ht­tp://www.na­tion­al­journ­al.com/early-bird. To send tips for Na­tion­al Journ­al‘s Early Bird, email early­bird@na­tion­al­journ­al.com.

“People have re­lied on the Pentagon’s Early Bird for 50 years — only slightly longer than they’ve re­lied on Na­tion­al Journ­al for fiercely hon­est cov­er­age of Wash­ing­ton’s most im­port­ant policy is­sues,” said Na­tion­al Journ­al Pres­id­ent Bruce Got­tlieb. “We’re ex­cited to pick up the torch and of­fer this crit­ic­al ser­vice to our read­ers.”

At its launch, Na­tion­al Journ­al‘s Early Bird will be com­piled by Na­tion­al Journ­al Cor­res­pond­ents Sara Sorch­er and Dustin Volz, with ad­di­tion­al staff con­trib­ut­ing. It will join Na­tion­al Journ­al‘s oth­er must-read news­let­ters: the mem­bers-only Need to Know Memo, The Edge, and Na­tion­al Journ­al‘s new­est news­let­ters, En­ergy Edge and Health Care Edge, all avail­able at ht­tp://www.na­tion­al­journ­al.com/news­let­ters.

The launch builds on Na­tion­al Journ­al‘s grow­ing suc­cess this fall. Traffic to Na­tion­al Journ­al‘s newly de­signed web­site is up sig­ni­fic­antly, set­ting an all-time re­cord in Septem­ber, which Oc­to­ber then sur­passed by 5 per­cent.

Ad­di­tion­ally, Monday’s news­let­ter draws on Na­tion­al Journ­al‘s her­it­age: Na­tion­al Journ­al once pub­lished a news­let­ter called Na­tion­al Journ­al‘s Early­bird ““ a pre­curs­or to today’s Need to Know Memo.

###

Me­dia Con­tact:
Emma V. Anger­er
Com­mu­nic­a­tions Dir­ect­or
eanger­er@na­tion­al­journ­al.com
(202) 266-7405

What We're Following See More »
DOWN FROM POST-CONVENTION NUMBERS
Monmouth Has Clinton Up Seven
8 minutes ago
THE LATEST

In a new Monmouth University poll, 46% of likely voters support Clinton and 39% back Trump, with 7% supporting Libertarian Gary Johnson, and 2% backing Jill Stein of the Green Party. That's down from a poll taken right after the Democratic convention, in which Clinton led by 13 points.

Source:
DEBATE PREP
Clinton Advisers Talking to Psychologists, Trump Ghostwriter
25 minutes ago
THE LATEST

“Hillary Clinton’s advisers are talking to Donald J. Trump’s ghostwriter of The Art of the Deal, seeking insights about Mr. Trump’s deepest insecurities as they devise strategies to needle and undermine him in four weeks at the first presidential debate, the most anticipated in a generation. ... Her team is also getting advice from psychology experts to help create a personality profile of Mr. Trump to gauge how he may respond to attacks and deal with a woman as his sole adversary on the debate stage.”

INFLUENCED BY NUKES, POLLUTION
Scientists Declare Dawn of Anthropocene Epoch
2 hours ago
WHY WE CARE

"Humanity’s impact on the Earth is now so profound that a new geological epoch—the Anthropocene—needs to be declared," according to a panel of scientists. "The new epoch should begin about 1950, the experts said, and was likely to be defined by the radioactive elements dispersed across the planet by nuclear bomb tests, although an array of other signals, including plastic pollution, soot from power stations, concrete, and even the bones left by the global proliferation of the domestic chicken."

Source:
EPI-PEN PRICES
House Committee Investigating Mylan
2 hours ago
THE LATEST

The House Committee on Oversight and Government Reform has requested documents from the CEO of Mylan, "the pharmaceutical company under fire after raising the price of EpiPens more than 400 percent since 2007." Meanwhile, top members of the Energy and Commerce Committee are pressing the FDA on the lack of generic competition for EpiPens.

Source:
×